relatlimab,nivolumab
bms
['lung', 'neopredict']
dr. martin schuler presenting neopredict lung, showing combination neoadjuvant immunotherapy is feasible and safe (and some interesting efficacy signals) #esmo22 
Oncologist, physician-scientist, Assistant Professor @YaleCancer @YaleMed | cancer immunotherapy, genomics, kidney cancer | tweets ? medical advice.